Amring Pharmaceuticals Inc. announces name change to Nordic Pharma, Inc. under new Nordic Group, B.V. ownership by merzdev | Mar 4, 2024 | NewsRead...
Nordic Group B.V. through its subsidiary Amring Pharmaceuticals Inc., appoints ophthalmology innovator, Eric D. Donnenfeld, MD as Medical Advisory Board Chair by merzdev | Feb 26, 2024 | NewsRead...
Nordic Group B.V. through its subsidiary Amring Pharmaceuticals Inc., announces Jai G. Parekh, MD, MBA as Chief Commercial Officer, Eye Care U.S. by merzdev | Jan 17, 2024 | NewsRead...
Nordic Pharma Group B.V. through its subsidiary Amring Pharmaceuticals Inc., completes acquisition of Visant Medical to launch novel therapy for dry eye disease in The United States by merzdev | Dec 18, 2023 | NewsRead...
